162 related articles for article (PubMed ID: 11585831)
1. The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells.
Le Roy F; Bisbal C; Silhol M; Martinand C; Lebleu B; Salehzada T
J Biol Chem; 2001 Dec; 276(51):48473-82. PubMed ID: 11585831
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway.
Bisbal C; Martinand C; Silhol M; Lebleu B; Salehzada T
J Biol Chem; 1995 Jun; 270(22):13308-17. PubMed ID: 7539425
[TBL] [Abstract][Full Text] [Related]
3. RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells.
Martinand C; Salehzada T; Silhol M; Lebleu B; Bisbal C
Eur J Biochem; 1998 Jun; 254(2):248-55. PubMed ID: 9660177
[TBL] [Abstract][Full Text] [Related]
4. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells.
Martinand C; Montavon C; Salehzada T; Silhol M; Lebleu B; Bisbal C
J Virol; 1999 Jan; 73(1):290-6. PubMed ID: 9847332
[TBL] [Abstract][Full Text] [Related]
5. The 2-5A/RNase L pathway and inhibition by RNase L inhibitor (RLI).
Bisbal C; Salehzada T; Silhol M; Martinand C; Le Roy F; Lebleu B
Methods Mol Biol; 2001; 160():183-98. PubMed ID: 11265282
[No Abstract] [Full Text] [Related]
6. The 2'-5' oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation.
Bisbal C; Silhol M; Laubenthal H; Kaluza T; Carnac G; Milligan L; Le Roy F; Salehzada T
Mol Cell Biol; 2000 Jul; 20(14):4959-69. PubMed ID: 10866653
[TBL] [Abstract][Full Text] [Related]
7. cDNA cloning and expression analysis of the murine ribonuclease L inhibitor.
Benoit De Coignac A; Bisbal C; Lebleu B; Salehzada T
Gene; 1998 Mar; 209(1-2):149-56. PubMed ID: 9524254
[TBL] [Abstract][Full Text] [Related]
8. Regulation of mitochondrial mRNA stability by RNase L is translation-dependent and controls IFNalpha-induced apoptosis.
Le Roy F; Silhol M; Salehzada T; Bisbal C
Cell Death Differ; 2007 Aug; 14(8):1406-13. PubMed ID: 17431428
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2-5A synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome.
Vojdani A; Choppa PC; Lapp CW
J Clin Lab Immunol; 1998; 50(1):1-16. PubMed ID: 10189612
[TBL] [Abstract][Full Text] [Related]
10. The 2-5A system in viral infection and apoptosis.
Castelli J; Wood KA; Youle RJ
Biomed Pharmacother; 1998; 52(9):386-90. PubMed ID: 9856285
[TBL] [Abstract][Full Text] [Related]
11. Characterization of RNABP, an RNA binding protein that associates with RNase L.
Le Roy F; Laskowska A; Silhol M; Salehzada T; Bisbal C
J Interferon Cytokine Res; 2000 Jul; 20(7):635-44. PubMed ID: 10926206
[TBL] [Abstract][Full Text] [Related]
12. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.
Castelli JC; Hassel BA; Wood KA; Li XL; Amemiya K; Dalakas MC; Torrence PF; Youle RJ
J Exp Med; 1997 Sep; 186(6):967-72. PubMed ID: 9294150
[TBL] [Abstract][Full Text] [Related]
13. The RNase L inhibitor (RLI) is induced by double-stranded RNA.
Martinand C; Salehzada T; Silhol M; Lebleu B; Bisbal C
J Interferon Cytokine Res; 1998 Dec; 18(12):1031-8. PubMed ID: 9877446
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal localization and expression pattern of the RNase L inhibitor gene.
Aubry F; Mattéi MG; Barque JP; Galibert F
FEBS Lett; 1996 Feb; 381(1-2):135-9. PubMed ID: 8641422
[TBL] [Abstract][Full Text] [Related]
15. Varicella-zoster virus does not significantly induce cell defence mechanism mediated by the 2-5A/RNase L pathway during its replication cycle.
Desloges N; Rahaus M; Wolff MH
Med Microbiol Immunol; 2005 Jan; 194(1-2):25-31. PubMed ID: 15107989
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 2',5'-oligo(A)-dependent endoribonuclease by 2',5'-oligo(A) degradation products.
Williams GJ; De Benedetti A; Baglioni C
Virology; 1986 Jun; 151(2):233-42. PubMed ID: 2422811
[TBL] [Abstract][Full Text] [Related]
17. RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response.
Li XL; Blackford JA; Judge CS; Liu M; Xiao W; Kalvakolanu DV; Hassel BA
J Biol Chem; 2000 Mar; 275(12):8880-8. PubMed ID: 10722734
[TBL] [Abstract][Full Text] [Related]
18. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
[TBL] [Abstract][Full Text] [Related]
19. Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.
Zhou A; Paranjape J; Brown TL; Nie H; Naik S; Dong B; Chang A; Trapp B; Fairchild R; Colmenares C; Silverman RH
EMBO J; 1997 Nov; 16(21):6355-63. PubMed ID: 9351818
[TBL] [Abstract][Full Text] [Related]
20. HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand.
Malathi K; Paranjape JM; Ganapathi R; Silverman RH
Cancer Res; 2004 Dec; 64(24):9144-51. PubMed ID: 15604285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
